What is the purpose of this trial?
The purpose of this study is to explore the possible links between patient characteristics and their cancer, with how effective the combination of nivolumab with ipilimumab is, in patients with Stage IV or recurrent Non-Small Cell Lung Cancer (NSCLC).
Ages: 18 years and older
Bristol-Myers Squibb Research and Development
Start Date: 04/20/2017
End Date: 01/01/2021
Last Updated: 02/21/2019
Study HIC#: 2000020087